Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome

Patient

Volumn 6, Issue 2, 2013, Pages 103-111

  Roset, Montse ^a   Badia, Xavier ^a   Forsythe, Anna ^b   Webb, Susan M ^c  

^a IQVIA   (United States)

^b Global Health Economics and Market Access   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL STUDY; CUSHING SYNDROME; CUSHINGQOL SCORE; DEMOGRAPHY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SHORT FORM 6D;

COST OF ILLNESS; CUSHING SYNDROME; EUROPE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PATIENT PREFERENCE; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 84880110112     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-013-0010-7     Document Type: Article

References (22)

1. Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593-602.
2. Newell-Price J, Bertagna X, Grossman AB, et al. Cushing's syndrome. Lancet. 2006;367:1605-17.
3. Tabarin A, Perez P. Pros and cons of screening for occult Cushing syndrome. Nat Rev Endocrinol. 2011;7:445-55.
4. van Aken MO, Pereira AM, Biermasz NR, et al. Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab. 2005;90:3279-86.
5. Lindsay JR, Nansel T, Baid S, et al. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab. 2006;91:447-53.
6. Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC. Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience. Ann Surg. 2007;245:790-4.
7. Guyatt GH. A taxonomy of health status instruments. J Rheumatol. 1995;22:1188-90.
8. Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17:13-35.
9. Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51:1115-28.
10. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337-43.
11. Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7:490-502.
12. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5:559-75.
13. Brazier JE, Yang Y, Tsuchiya A, et al. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11:215-25.
14. Webb SM, Badia X, Barahona MJ, et al. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. Eur J Endocrinol. 2008;158:623-30.
15. Ware JE Jr, Sherbourne CD. The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-83.
16. Badia X, Barahona MJ, Glusman J, et al. Strategy for developing a specific Cushing's syndrome QoL questionnaire. In: 12th ISOQOL conference on patient reported outcomes in clinical practice. Budapest (Hungary), 2007 June 24-26 (Abstract).
17. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute; 1994.
18. Brazier J, Roberts J, Deverill M. The estimation of a preference based single index measure for health from the SF-36. J Health Econ. 2002;21:271-92.
19. Cheung YB, Tan LC, Lau PN, Au WL, Luo N. Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index. Qual Life Res. 2008;17:1173-81.
20. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17:1623-34.
21. Wu EQ, Mulani P, Farrell MH, et al. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value Health. 2007;10:408-14.
22. Valassi E, Santos A, Yaneva M, et al. The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol. 2011;165:383-92.